{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:35:37Z","timestamp":1792510537135,"version":"4.5.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.6468","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T22:50:49Z","timestamp":1619131849000},"page":"e216468","source":"Crossref","is-referenced-by-count":127,"title":["Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19"],"prefix":"10.1001","volume":"4","author":[{"given":"Gilmar","family":"Reis","sequence":"first","affiliation":[{"name":"Research Division, Cardresearch\u2014Cardiologia Assistencial e de Pesquisa, Brazil"},{"name":"Department of Medicine, Pontif\u00edcia Universidade Cat\u00f3lica de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Augusto dos Santos","family":"Moreira Silva","sequence":"additional","affiliation":[{"name":"Research Division, Cardresearch\u2014Cardiologia Assistencial e de Pesquisa, Brazil"},{"name":"Department of Medicine, Pontif\u00edcia Universidade Cat\u00f3lica de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Carla","family":"Medeiros Silva","sequence":"additional","affiliation":[{"name":"Research Division, Cardresearch\u2014Cardiologia Assistencial e de Pesquisa, Brazil"},{"name":"Department of Medicine, Pontif\u00edcia Universidade Cat\u00f3lica de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurmit","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay J. H.","family":"Park","sequence":"additional","affiliation":[{"name":"Experimental Medicine, Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Cytel Inc, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie I.","family":"Forrest","sequence":"additional","affiliation":[{"name":"Experimental Medicine, Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Cytel Inc, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofir","family":"Harari","sequence":"additional","affiliation":[{"name":"Cytel Inc, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Castilho Vitor","family":"Quirino dos Santos","sequence":"additional","affiliation":[{"name":"Research Division, Cardresearch\u2014Cardiologia Assistencial e de Pesquisa, Brazil"},{"name":"Department of Medicine, Pontif\u00edcia Universidade Cat\u00f3lica de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Figueiredo","family":"Guimar\u00e3es de Almeida","sequence":"additional","affiliation":[{"name":"Department of Public Health, Montes Claros State University, Montes Claros, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adhemar Dias de","family":"Figueiredo Neto","sequence":"additional","affiliation":[{"name":"Public Health Fellowship Program, Governador Valadares Public Health Authority, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Can\u00e7ado Monteiro","family":"Savassi","sequence":"additional","affiliation":[{"name":"Public Health, Mental and Family Medicine Department, Ouro Preto Federal University, Ouro Preto, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Cruz","family":"Milagres","sequence":"additional","affiliation":[{"name":"Public Health, Mental and Family Medicine Department, Ouro Preto Federal University, Ouro Preto, Brazil"},{"name":"Public Health Care Division, City of Ibirit\u00e9, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro Martins","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Drug Research and Development Center, Federal University of Minas Gerais, Belo Horizonte, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Izabel Campos","family":"Simplicio","sequence":"additional","affiliation":[{"name":"Research Division, Cardresearch\u2014Cardiologia Assistencial e de Pesquisa, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciene Barra","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Research Division, Cardresearch\u2014Cardiologia Assistencial e de Pesquisa, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Research Division, Cardresearch\u2014Cardiologia Assistencial e de Pesquisa, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Mills","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"TOGETHER Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"issue":"10","key":"zoi210214r2","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMc2022236","article-title":"Remdesivir for the treatment of Covid-19\u2013preliminary report.","volume":"383","author":"Gillenwater","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi210214r3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19.","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"issue":"10223","key":"zoi210214r4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"zoi210214r5","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.4269\/ajtmh.20-0995","article-title":"Accelerating clinical evaluation of repurposed combination therapies for COVID-19.","volume":"103","author":"Rayner","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"zoi210214r6","doi-asserted-by":"publisher","first-page":"e1249","DOI":"10.1016\/S2214-109X(20)30365-X","article-title":"Clinical trials of disease stages in COVID 19: complicated and often misinterpreted.","volume":"8","author":"Park","year":"2020","journal-title":"Lancet Glob Health"},{"key":"zoi210214r7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"issue":"15","key":"zoi210214r8","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","volume":"71","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi210214r9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcv.2004.03.003","article-title":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.","volume":"31","author":"Chen","year":"2004","journal-title":"J Clin Virol"},{"issue":"12","key":"zoi210214r10","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with lopinavir\/ritonavir or interferon-\u00df1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset.","volume":"212","author":"Chan","year":"2015","journal-title":"J Infect Dis"},{"issue":"4","key":"zoi210214r11","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.4269\/ajtmh.20-0873","article-title":"Hydroxychloroquine in the treatment of COVID-19: a multicenter randomized controlled study.","volume":"103","author":"Abd-Elsalam","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"10259","key":"zoi210214r12","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(20)32013-4","article-title":"Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.","volume":"396","author":"RECOVERY Collaborative Group","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"zoi210214r13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40121-020-00349-8","article-title":"Early treatment of COVID-19 disease: a missed opportunity.","volume":"9","author":"Forrest","year":"2020","journal-title":"Infect Dis Ther"},{"issue":"3","key":"zoi210214r14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/1740774515626362","article-title":"Efficiencies of platform clinical trials: a vision of the future.","volume":"13","author":"Saville","year":"2016","journal-title":"Clin Trials"},{"key":"zoi210214r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2020.04.025","article-title":"An overview of platform trials with a checklist for clinical readers.","volume":"125","author":"Park","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"zoi210214r16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/s13063-019-3664-1","article-title":"Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols.","volume":"20","author":"Park","year":"2019","journal-title":"Trials"},{"issue":"1","key":"zoi210214r17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMra1510062","article-title":"Master protocols to study multiple therapies, multiple diseases, or both.","volume":"377","author":"Woodcock","year":"2017","journal-title":"N Engl J Med"},{"key":"zoi210214r18","doi-asserted-by":"crossref","first-page":"m115","DOI":"10.1136\/bmj.m115","article-title":"The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.","volume":"369","author":"Dimairo","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"zoi210214r19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s13063-020-04334-x","article-title":"The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.","volume":"21","author":"Dimairo","year":"2020","journal-title":"Trials"},{"issue":"2","key":"zoi210214r20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1056\/NEJMc2008646","article-title":"Early detection of Covid-19 through a citywide pandemic surveillance platform.","volume":"383","author":"Chu","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi210214r21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jclinepi.2004.11.019","article-title":"The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid.","volume":"58","author":"Barrett","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"zoi210214r22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194180","article-title":"Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI).","volume":"13","author":"Powers","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"zoi210214r23","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00821-20","article-title":"Comparison of commercially available and laboratory-developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories.","volume":"58","author":"Lieberman","year":"2020","journal-title":"J Clin Microbiol"},{"key":"zoi210214r24","article-title":"Utilizing Bayesian predictive power in clinical trial design.","author":"Harari","year":"2020","journal-title":"Pharm Stat"},{"issue":"7","key":"zoi210214r25","doi-asserted-by":"crossref","DOI":"10.3390\/v12070705","article-title":"Repurposing therapeutics for potential treatment of SARS-CoV-2: a review.","volume":"12","author":"Santos","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"zoi210214r26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4269\/ajtmh.20-1320","article-title":"The rise and fall of hydroxychloroquine for the treatment and prevention of COVID-19.","volume":"104","author":"Lee","year":"2021","journal-title":"Am J Trop Med Hyg."},{"issue":"10238","key":"zoi210214r27","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"},{"key":"zoi210214r28","article-title":"Hydroxychloroquine for early treatment of adults with mild Covid-19: a randomized-controlled trial.","author":"Mitj\u00e0","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"zoi210214r29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.7326\/M20-4207","article-title":"Hydroxychloroquine in nonhospitalized adults with early COVID-19 : a randomized trial.","volume":"173","author":"Skipper","year":"2020","journal-title":"Ann Intern Med"},{"issue":"6","key":"zoi210214r30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMe2020388","article-title":"Hydroxychloroquine for the prevention of Covid-19 - searching for evidence.","volume":"383","author":"Cohen","year":"2020","journal-title":"N Engl J Med"},{"key":"zoi210214r31","article-title":"Repurposed antiviral drugs for Covid-19 - interim WHO solidarity trial results.","author":"Pan","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi210214r32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19.","volume":"383","author":"Boulware","year":"2020","journal-title":"N Engl J Med"},{"key":"zoi210214r1","unstructured":"Johns Hopkins University & Medicine. Coronavirus Resource Center. September 10, 2020. Accessed November 19, 2020. https:\/\/coronavirus.jhu.edu"},{"key":"zoi210214r33","unstructured":"Drugs for Neglected Diseases Institute. The ANTICOV trial. Accessed December 5, 2020. https:\/\/dndi.org\/diseases\/covid-19\/"},{"key":"zoi210214r34","unstructured":"Clincialtrials.gov. Trial of early therapies during non-hospitalized outpatient window for COVID-19 (TREATNOW). Accessed December 5, 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04372628"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2779044\/reis_2021_oi_210214_1631721378.05543.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T15:00:55Z","timestamp":1631890855000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2779044"}},"subtitle":["The TOGETHER Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.6468","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,22]]}}}